I don't think much of a connection between SGNX, RGRX or QCOR......because of Cavazzzas. if that was true??? EVERY QCOR holder woudl be all over RGRX, because Cavass were vbuying QCOR in 25 to 50 cent range hugely. And QCOR is now $27.00!! It's the QCOR players that shoudl be buying RGRX if they follow Cavazza sucess.
SGNX? Who knows. But why does it get triple market cap and trade 1 million (or more) a day. RGRX has traded about 21,000 shares. The total value in dollars of todays trading is $4,000.
So it's clear to me, no one draws or sees any connection to RGRX or any cavazas holdings.
I thoiought that dosing tidbit VERY important bo......the FDA blessed this phase 2 dry eye by ORA...with NO demand for dose ranging limitations. RGRX and ORA chose the highest dose and went with it. i do think think improves chances of "Statistical" win. Because if RGRX had to dose a LOW end TB 4 at say, 0.02% the chances of good efficacy VERY slim. And THAt screws up all statistiacl measures and P values.